
|Articles|July 2, 2017
Orphan Drug Evaluation Overhaul Highlights AJPB Week in Review
Author(s)AJPB staff
Top articles of the week from The American Journal of Pharmacy Benefits.
Advertisement
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
3
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
4
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
5














































































































































































































